Enantioselective Hydroformylation of 1-Alkenes with Commercial Ph-BPE Ligand.Org Lett. 2015 Jul 02; 17(13):3264-7.OL
Abstract
A rhodium complex, in conjunction with commercially available Ph-BPE ligand, catalyzes the branch-selective asymmetric hydroformylation of 1-alkenes and rapidly generates α-chiral aldehydes. A wide range of terminal olefins including 1-dodecene were examined, and all delivered high enantioselectivity (up to 98:2 er) as well as good branch:linear ratios (up to 15:1).
Links
MeSH
Pub Type(s)
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Language
eng
PubMed ID
26091063
Citation
Yu, Zhiyong, et al. "Enantioselective Hydroformylation of 1-Alkenes With Commercial Ph-BPE Ligand." Organic Letters, vol. 17, no. 13, 2015, pp. 3264-7.
Yu Z, Eno MS, Annis AH, et al. Enantioselective Hydroformylation of 1-Alkenes with Commercial Ph-BPE Ligand. Org Lett. 2015;17(13):3264-7.
Yu, Z., Eno, M. S., Annis, A. H., & Morken, J. P. (2015). Enantioselective Hydroformylation of 1-Alkenes with Commercial Ph-BPE Ligand. Organic Letters, 17(13), 3264-7. https://doi.org/10.1021/acs.orglett.5b01421
Yu Z, et al. Enantioselective Hydroformylation of 1-Alkenes With Commercial Ph-BPE Ligand. Org Lett. 2015 Jul 2;17(13):3264-7. PubMed PMID: 26091063.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Enantioselective Hydroformylation of 1-Alkenes with Commercial Ph-BPE Ligand.
AU - Yu,Zhiyong,
AU - Eno,Meredith S,
AU - Annis,Alexandra H,
AU - Morken,James P,
Y1 - 2015/06/19/
PY - 2015/6/20/entrez
PY - 2015/6/20/pubmed
PY - 2015/11/11/medline
SP - 3264
EP - 7
JF - Organic letters
JO - Org Lett
VL - 17
IS - 13
N2 - A rhodium complex, in conjunction with commercially available Ph-BPE ligand, catalyzes the branch-selective asymmetric hydroformylation of 1-alkenes and rapidly generates α-chiral aldehydes. A wide range of terminal olefins including 1-dodecene were examined, and all delivered high enantioselectivity (up to 98:2 er) as well as good branch:linear ratios (up to 15:1).
SN - 1523-7052
UR - https://www.unboundmedicine.com/medline/citation/26091063/Enantioselective_Hydroformylation_of_1_Alkenes_with_Commercial_Ph_BPE_Ligand_
DB - PRIME
DP - Unbound Medicine
ER -